Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis.
The primary purpose of this study was to compare changes in cognition in early-onset psychosis after 6-months treatment with quetiapine or olanzapine. This is a randomized, single-blind, 6-month study in 50 adolescents with a diagnosis of early-onset psychosis. Patients were randomized to quetiapine (n = 24) or olanzapine (n =26). A thorough neuropsychological battery was administered at baseline and after 6-month treatment. Out of the total sample included in the study, 32 patients completed at least 6-months treatment with the assigned medication (quetiapine, n =16; olanzapine, n = 16). No changes were observed in cognitive performance after 6-month treatment with quetiapine or olanzapine. Although some trends toward cognitive improvement were observed for the olanzapine group after 6-month treatment, neither group showed statistically significant gains. Furthermore, there was no evidence of any differential efficacy of olanzapine or quetiapine on cognitive improvement in this sample of adolescents with psychosis.
Robles
Olalla
O
Adolescent Unit, Psychiatry Department, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Zabala
Arantzazu
A
Bombín
Igor
I
Parellada
Mara
M
Moreno
Dolores
D
Ruiz-Sancho
Ana
A
Arango
Celso
C
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests / Q000706:statistics & numerical data*; D000077152:Olanzapine; D011594:Psychometrics; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000069348:Quetiapine Fumarate; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016037:Single-Blind Method; D013030:Spain; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D000077152:Olanzapine
J Abnorm Psychol. 1989 Nov;98(4):367-80
2574202
Schizophr Res. 2001 Mar 1;48(1):17-28
11278151
Am J Psychiatry. 1996 Mar;153(3):321-30
8610818
Am J Psychiatry. 2009 Jun;166(6):675-82
19369319
Schizophr Res. 2002 Jan 1;53(1-2):7-16
11728833
Schizophr Bull. 1998;24(1):147-52
9502552
Schizophr Res. 2000 Apr 7;42(2):135-44
10742651
Biol Psychiatry. 1998 Sep 15;44(6):488-92
9777181
Schizophr Bull. 2005 Jan;31(1):5-19
15888422
Biol Psychiatry. 1984 May;19(5):745-53
6733182
Arch Gen Psychiatry. 2007 Jun;64(6):633-47
17548746
Am J Psychiatry. 1999 Sep;156(9):1358-66
10484945
Neuropsychology. 1998 Jul;12(3):426-45
9673998
J Psychiatry Neurosci. 2001 Mar;26(2):137-49
11291531
Arch Gen Psychiatry. 2007 Oct;64(10):1115-22
17909123
Eur Neuropsychopharmacol. 2004 Nov;14 Suppl 4:S471-9
15572266
Schizophr Bull. 1994;20(1):31-46
8197420
Schizophr Res. 2002 Oct 1;57(2-3):209-19
12223252
Neuropsychopharmacology. 2004 Jan;29(1):133-45
14583740
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):233-8
15694229
Schizophr Bull. 1990;16(3):477-99
1981108
Biol Psychiatry. 2005 Nov 1;58(9):705-12
16023084
Schizophr Res. 2000 Dec 15;46(2-3):81-9
11120419
Arch Gen Psychiatry. 1991 Jul;48(7):618-24
2069492
Schizophr Res. 1999 Mar 1;35 Suppl:S51-60
10190225
Biol Psychiatry. 2002 Jun 15;51(12):969-71
12062880
Psychiatry Res. 2004 Dec 15;129(2):159-69
15590043
J Clin Psychopharmacol. 1998 Apr;18(2 Suppl 1):12S-9S
9555611
Schizophr Bull. 2006 Oct;32(4):666-78
16829550
Am J Psychiatry. 2005 Oct;162(10):1888-95
16199835
Encephale. 2006 May-Jun;32(3 Pt 1):341-50
16840928
Schizophr Res. 2005 Oct 1;78(1):35-43
15978781
Schizophr Res. 2004 May 1;68(1):49-63
15037339
Am J Psychiatry. 1999 Sep;156(9):1328-35
10484941
Am J Psychiatry. 2001 Feb;158(2):176-84
11156796
Schizophr Bull. 2005 Jul;31(3):705-22
16006592
Schizophr Bull. 1994;20(4):599-617
7701271
Eur Child Adolesc Psychiatry. 2009 Jul;18(7):418-28
19198920
Am J Psychiatry. 2000 Apr;157(4):514-20
10739409
Schizophr Res. 2002 Jan 15;53(3):239-48
11738537
Biol Psychiatry. 2004 Sep 1;56(5):301-7
15336511
Arch Gen Psychiatry. 1997 Feb;54(2):159-65
9040284
Eur Psychiatry. 2005 Aug;20(5-6):395-402
16171654
Schizophr Res. 2006 Jan 1;81(1):29-39
16263246
J Clin Psychopharmacol. 2003 Aug;23(4):400-4
12920417
Schizophr Bull. 1999;25(2):201-22
10416727
Schizophr Res. 2004 May 1;68(1):21-6
15037336
J Clin Psychiatry. 2006 Oct;67(10):e12
17107235
Biol Psychiatry. 1994 Dec 1;36(11):717-25
7858067
Eur Neuropsychopharmacol. 2005 Oct;15(5):525-31
16139171
Br J Psychiatry. 1990 Dec;157:799-811
1981157
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):219-32
15694228
Arch Gen Psychiatry. 2000 Mar;57(3):249-58
10711911